Observation of the Efficacy of Leflunomide and Methotrexate in the Treatment of Rheumatoid Arthritis

钟清,甘华,陈恩静,李曼丽

DOI: https://doi.org/10.3969/j.issn.0253-3626.2003.04.029

2003-01-01

Abstract:Objective:To evaluate the efficacy and safety of leflunomide (LEF) in comparison with methotrexate (MTX) in treatment of rheumatoid arthritis (RA).Methods:50 patients with active RA were randomly divided into two groups.The first group received 20 mg daily LEF.The second group received small dose (7.5～10 mg weekly) of MTX.We compared the degree of the morning stiffness and the number of swelling,aching joints and the change of ESR,CRP and RF in RA patients between LEF group and MTX group.Results:The response rate in the LEF group was higher than that in the MTX group 1 month later( P 0.05).The response rate was not different between the LEF group and the MTX group 3 months later ( P 0.05).1 month after therapy,the clinical situation and experimental findings were much ameliorated in LEF group as compared with before ( P 0.05).Significant difference in the clinical manifestations and experimental findings were found between LEF group and MTX group ( P 0.05).3 months after therapy,the clinical situation and experiment findings were much ameliorated in both groups ( P 0.001) .No significant difference in the clinical manifestations and experimental findings were found between LEF group and MTX group ( P 0.05) . The incidence of adverse events for LEF and MTX groups were 3/30 and 2/20 respectively , and there was no significant difference ( P 0.05).Conclusion:LEF is an effective agent for treatment ofRA with better tolerability,and there are few adverse effects.